Data for (Study ST000681)

(Analysis AN001048)

Values for each metabolite have been scaled by dividing by the mean across all factors

Run Hierarchial cluster analysis on this study | Run Heatmap cluster analysis on this study

MetaboliteF1F2F3F4F5
CL 70:3; [M-2H](2-)@9.57 1.0424 1.0906 0.8850 1.0081 1.0420
CL 72:4; [M-2H](2-)@9.62 1.1129 1.1592 0.9681 0.7889 0.8138
CL 72:5; [M-2H](2-)@9.44 0.9645 1.5726 0.9603 0.7258 0.6323
CL 74:7; [M-2H](2-)@9.52 1.2690 0.9843 1.0023 0.6075 0.7840
CL 76:11; [M-2H](2-)@9.02 1.0952 1.1116 0.9560 0.7079 0.9323
FFA(16:0) 1.1694 0.9257 0.9801 0.9439 0.9003
FFA(18:0) 1.1563 0.9452 0.9841 0.9358 0.8942
FFA(18:1) 1.2749 0.8900 1.0037 0.8647 0.7824
FFA(18:2) 1.4381 0.9825 0.8597 0.7456 0.7519
FFA(20:0) 1.0842 0.8768 1.0588 1.0089 0.9100
FFA(20:1) 1.1554 1.0104 0.9405 0.9568 0.8959
FFA(20:2) 1.3823 0.8520 0.9302 0.7873 0.8255
FFA(20:4) Arachidonic acid 1.0815 0.8551 1.0065 1.1106 0.9884
FFA(22:0) 1.1108 0.8891 1.0471 0.9811 0.8910
FFA(22:1) 0.9880 0.9106 1.1260 0.9145 0.9238
FFA(22:2) 1.1601 1.0873 0.9945 1.0507 0.6915
FFA(22:3) 1.3475 0.9830 0.9214 0.9339 0.7067
FFA(24:0) 1.0129 1.3712 0.9261 1.2520 0.6508
FFA(24:1) 1.0960 0.7352 1.0643 1.0314 1.0192
FFA(24:3) 1.3726 0.9577 0.7870 1.2057 0.8319
N-(hexadecanoyl)-sphing-4-enine; [M-H]-@6.77 1.6905 0.7497 0.9037 0.4991 0.6569
N-(octadecanoyl)-sphing-4-enine; [M-H]-@7.37 1.2902 0.8333 0.9868 0.8160 0.8631
PC 28:0; [M-Ac-H]-@5.17 1.0477 0.7464 1.0721 1.3300 0.9599
PC 30:0; [M-Ac-H]-@5.85 1.0979 0.8902 1.0913 0.9454 0.8452
PC 31:0; [M-Ac-H]-@6.20 1.2075 0.8520 1.0320 0.9668 0.8292
PC 32:0; [M-Ac-H]-@6.46 1.0565 0.9126 1.0611 0.9370 0.9312
PC 32:1; [M-Ac-H]-@5.99 1.0274 0.8854 1.0893 1.0464 0.9138
PC 32:2; [M-Ac-H]-@5.53 1.2445 0.9531 0.7924 1.3083 0.9641
PC 33:1; [M-Ac-H]-@6.36 1.2672 0.8201 0.9812 1.0742 0.8302
PC 33:2; [M-Ac-H]-@5.88 0.9265 1.1365 0.9759 1.8158 0.7297
PC 34:1; [M-Ac-H]-@6.57 1.1248 0.9424 1.0340 0.9804 0.8411
PC 34:2; [M-Ac-H]-@6.14 1.0591 0.8608 1.1002 0.9717 0.9028
PC 34:3; [M-Ac-H]-@5.66 1.0623 1.1433 1.0339 1.2560 0.6318
PC 35:1; [M-Ac-H]-@6.96 1.1412 0.7764 1.0960 0.9049 0.9070
PC 36:0; [M-Ac-H]-@7.66 1.1255 0.8609 1.0812 0.8787 0.8769
PC 36:1; [M-Ac-H]-@7.16 1.1238 0.9309 1.0588 0.8996 0.8395
PC 36:2; [M-Ac-H]-@6.73 1.1008 0.8666 0.9956 1.0673 0.9839
PC 36:3; [M-Ac-H]-@6.37 1.1121 1.0002 1.0313 0.9188 0.8253
PC 36:4; [M-Ac-H]-@6.12 1.0626 0.9304 1.0292 1.0813 0.9105
PC 36:5; [M-Ac-H]-@5.60 0.7210 0.7549 1.1452 1.2445 1.2935
PC 36:6; [M-Ac-H]-@5.40 1.0087 0.8534 1.0399 1.0218 1.0612
PC 37:4; [M-Ac-H]-@6.44 1.1444 1.0977 0.9983 0.8780 0.7532
PC 37:6; [M-Ac-H]-@5.74 1.0153 0.9226 1.1030 1.1144 0.8472
PC 38:1; [M-Ac-H]-@7.73 1.1069 0.8416 1.0651 0.9740 0.9161
PC 38:2; [M-Ac-H]-@7.31 1.0216 0.8794 1.0151 1.1427 1.0190
PC 38:3; [M-Ac-H]-@7.00 1.0848 0.8695 1.0382 1.0946 0.9222
PC 38:4; [M-Ac-H]-@6.68 1.1285 0.9832 0.9795 1.0207 0.8728
PC 38:5; [M-Ac-H]-@6.33 1.0873 0.8994 1.0895 0.7490 0.9187
PC 38:6; [M-Ac-H]-@5.97 0.9744 1.0745 1.0538 0.9880 0.8740
PC 39:6; [M-Ac-H]-@6.35 1.1561 1.0033 0.9110 1.0425 0.9228
PC 40:2; [M-Ac-H]-@7.96 1.2124 0.7733 0.9970 1.0523 0.9310
PC 40:4; [M-Ac-H]-@7.22 1.0635 1.1818 0.9834 0.9016 0.7941
PC 40:6; [M-Ac-H]-@6.60 1.0601 0.9859 0.9807 1.0638 0.9449
PC 40:7; [M-Ac-H]-@6.14 0.9878 0.9923 1.0914 0.9298 0.8951
PC 42:6; [M-Ac-H]-@7.30 1.1860 1.0800 0.8206 1.2985 0.8715
PC 42:7; [M-Ac-H]-@6.75 1.1611 0.8917 1.0138 0.9171 0.8982
PC 44:12; [M-Ac-H]-@5.49 0.9343 1.0379 1.0507 1.0322 0.9545
PE 32:0; [M-H]-@6.67 1.1537 1.0637 0.9340 0.9436 0.8601
PE 35:0; [M-H]-@7.50 1.1180 0.9991 1.0101 1.1780 0.7675
PE 35:4; [M-H]-@6.00 1.0923 0.8858 1.1879 0.2103 0.9412
PE 36:0; [M-H]-@7.77 1.0827 0.9922 0.9939 1.0668 0.8855
PE 36:1; [M-H]-@7.34 1.0907 0.7783 1.0671 1.0554 0.9705
PE 36:3; [M-H]-@6.46 1.1357 0.8757 1.0354 0.8618 0.9305
PE 37:4; [M-H]-@6.63 1.1588 0.8389 1.0779 0.5632 0.9652
PE 38:1; [M-H]-@7.83 1.0767 1.0064 0.9212 1.0081 1.0200
PE 38:3; [M-H]-@7.23 1.1195 1.0557 0.9237 0.9677 0.9229
PE 40:10; [M-H]-@5.07 1.0169 0.8585 0.9882 1.1293 1.0955
PE 40:9; [M-H]-@5.52 0.8673 1.2502 0.8949 1.2570 1.0161
PE 41:6; [M-H]-@7.06 1.0056 0.9321 0.9515 0.9797 1.1480
PE 42:10; [M-H]-@5.77 1.0576 0.9168 1.0607 0.9846 0.9102
PE 42:6; [M-H]-@7.40 0.8198 1.2632 0.9346 1.0604 1.0659
PE 42:9; [M-H]-@6.05 0.9779 0.9906 1.0360 1.1341 0.9341
PE 44:10; [M-H]-@6.29 1.0790 1.0300 0.9460 1.0207 0.9477
PE 44:12; [M-H]-@5.65 0.9295 0.9919 1.0497 1.1325 0.9752
PG 32:0; [M-H]-@5.77 1.1719 1.0189 0.9847 0.7038 0.8763
PG 33:0; [M-H]-@6.04 1.1598 0.9800 0.9341 0.4018 1.1162
PG 34:1; [M-H]-@5.81 1.0552 0.8922 1.0764 1.0018 0.9064
PG 34:2; [M-H]-@5.43 0.9750 1.2483 0.9607 1.1263 0.8085
PG 36:2; [M-H]-@5.94 1.1292 0.9537 1.0359 0.9735 0.8230
PG 36:3; [M-H]-@5.61 1.0257 1.0664 0.9906 0.9141 0.9437
PG 36:4; [M-H]-@5.42 1.0380 1.0781 1.0070 1.0063 0.8576
PG 36:5; [M-H]-@5.05 0.8180 0.9085 1.1909 1.5120 0.8453
PG 38:4; [M-H]-@6.02 1.1079 0.9722 1.0196 1.0220 0.8439
PG 38:5; [M-H]-@5.55 1.0035 0.9813 1.0396 0.9068 0.9790
PG 38:6; [M-H]-@5.35 1.0236 0.9785 0.9872 0.8952 1.0464
PG 40:6; [M-H]-@5.98 1.0539 0.9171 1.0561 1.0264 0.9087
PG 40:7; [M-H]-@5.18 1.1628 1.0148 1.0346 0.7542 0.7924
PG 40:8; [M-H]-@4.65 1.0992 1.1181 0.9116 0.8088 0.9607
PG 42:10; [M-H]-@4.63 0.9450 1.0301 0.9902 1.1451 1.0112
PG 42:9; [M-H]-@4.87 0.7707 1.5699 0.8021 1.0433 1.0512
PG 44:10; [M-H]-@5.10 0.8507 1.1890 1.0468 0.9154 0.9604
PG 44:11; [M-H]-@4.74 0.9436 0.9548 1.0618 1.0031 1.0164
PG 44:12; [M-H]-@4.48 1.0255 0.8897 0.9831 1.0721 1.0804
PI 36:2; [M-H]-@5.93 0.9105 0.9691 1.0492 1.2040 1.0003
PI 36:4; [M-H]-@5.21 1.0800 1.2460 0.9045 0.9194 0.8334
PI 38:4; [M-H]-@5.87 1.0209 1.1618 1.0386 0.9290 0.7696
plasmenyl-PE 32:0; [M-H]-@7.01 0.9659 1.0856 1.0062 1.1150 0.9113
plasmenyl-PE 32:1; [M-H]-@6.51 1.1382 0.8266 1.1100 0.7826 0.8782
plasmenyl-PE 34:1; [M-H]-@7.07 1.2254 0.8150 0.9936 0.8683 0.9390
plasmenyl-PE 34:2; [M-H]-@6.64 1.1589 0.8687 1.0245 0.7945 0.9471
plasmenyl-PE 36:3; [M-H]-@6.89 1.0784 1.0421 0.9824 1.0319 0.8720
plasmenyl-PE 38:1; [M-H]-@8.13 1.0100 0.9743 0.9922 1.2017 0.9581
plasmenyl-PE 38:2; [M-H]-@7.79 0.9661 1.1063 1.0311 0.9350 0.9088
plasmenyl-PE 38:3; [M-H]-@7.52 1.1096 0.9764 0.9613 1.0739 0.9174
plasmenyl-PE 42:5; [M-H]-@7.79 1.0864 0.9312 0.9781 1.0228 0.9824
PS 34:1; [M-H]-@5.98 1.0328 0.8466 1.1131 1.0873 0.8920
PS 34:2; [M-H]-@5.30 0.9897 1.1767 1.0013 0.9574 0.8491
PS 36:2; [M-H]-@5.98 1.0445 0.9039 1.0998 1.0313 0.8599
PS 36:4; [M-H]-@5.31 1.1848 0.9959 0.9922 0.9957 0.7722
PS 38:3; [M-H]-@6.19 1.0892 1.0475 0.9502 1.0664 0.8944
PS 38:4; [M-H]-@5.94 1.0357 0.8671 1.0945 1.1661 0.8725
PS 38:5; [M-H]-@5.52 0.9243 0.7747 1.1537 0.7427 1.1559
PS 38:6; [M-H]-@5.21 1.1372 0.7339 1.0319 0.9480 1.0473
PS 40:4; [M-H]-@6.46 1.0727 1.0084 0.9303 1.0213 1.0036
PS 40:6; [M-H]-@5.89 1.0288 0.8681 1.0952 1.0585 0.9152
PS 40:7; [M-H]-@5.37 1.0304 1.0823 1.0613 0.8394 0.8285
PS 40:8; [M-H]-@4.86 0.8388 1.3100 1.1775 0.7347 0.6974
PS 42:10; [M-H]-@4.80 1.2183 0.9583 0.9725 1.2039 0.7284
PS 42:11; [M-H]-@4.38 0.9448 1.0460 1.0727 1.1322 0.8624
PS 42:6; [M-H]-@6.50 0.9274 1.0014 0.9947 1.2128 1.0334
PS 42:7; [M-H]-@5.99 1.0322 1.0448 1.0660 0.9870 0.8066
PS 42:9; [M-H]-@5.07 1.1332 1.3129 0.8328 0.7001 0.8881
PS 44:10; [M-H]-@5.31 0.9377 1.2298 0.9380 1.0163 0.9512
PS 44:11; [M-H]-@4.92 0.8667 1.1651 0.9378 1.1707 1.0594
PS 44:12; [M-H]-@4.69 0.8534 0.9997 1.0208 1.2266 1.0856
Run Hierarchial cluster analysis on this study | Run Heatmap cluster analysis on this study

Factors:

F1CRE:LysM Cre | SEX:f
F2CRE:negative | SEX:f
F3CRE:negative | SEX:m
F4CRE:Tyrosinase Cre | SEX:f
F5CRE:Tyrosinase Cre | SEX:m
  logo